Takeda Pharmaceutical
310 hedge funds and large institutions have $1.32B invested in Takeda Pharmaceutical in 2023 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 90 increasing their positions, 97 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
310
Holders Change
+10
Holders Change %
+3.33%
% of All Funds
4.89%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
41
Increased
90
Reduced
97
Closed
28
Calls
$44.7M
Puts
$5.98M
Net Calls
+$38.7M
Net Calls Change
+$7.05M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
$36.7M |
| 2 |
Jane Street
New York
|
$15.7M |
| 3 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
$13.6M |
| 4 |
Renaissance Technologies
New York
|
$57.3M |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
$9.48M |
Top Sellers
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
$22.5M |
| 2 |
Barclays
London,
United Kingdom
|
$814K |
| 3 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
$43.7M |
| 4 |
Millennium Management
New York
|
$48.5M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
$14.1M |
